Vitality Watch

Dossier pubmed preclinical 01-sep-2026
Animal model, organoid, or cell-culture result — not yet human

NADMetabolic Reprogramming Drives CD8T Cells Senescence and Exacerbates Ulcerative Colitis.

Key claim: NAD metabolic dysregulation drives mitochondrial dysfunction and mtDNA–cGAS–STING–dependent CD8 T-cell senescence that exacerbates ulcerative colitis, and clearing these senescent cells with senolytics attenuates disease.

Abstract

While immunosenescence is increasingly implicated in chronic inflammatory disorders, its precise pathogenic contribution to ulcerative colitis (UC) remains elusive. Here, we identify senescent CD8T cells as a distinct pathogenic population that exacerbates colitis, demonstrating that systemic senolytic treatment significantly attenuates disease severity. Mechanistically, nicotinamide adenine dinucleotide (NAD) metabolic dysregulation triggers mitochondrial dysfunction and cytosolic mitochondrial DNA leakage, promoting CD8T cell senescence through the activation of the cGAS-STING signaling pathway. Spatial transcriptomic mapping reveals that senescent CD8T cells are enriched within mucosal niches experiencing NADmetabolic dysregulation. Crucially, this senescent-metabolic signature correlates with severe disease phenotypes and predicts non-response to biologic therapies in UC patients. Collectively, our findings uncover a critical NAD-cGAS-STING axis driving T cell senescence, establishing the clearance of senescent immune cells as a promising therapeutic strategy for UC.

Why this matters

Ulcerative colitis is reframed here as a disease where an aging-biology cascade — NAD depletion, mitochondrial dysfunction, mtDNA leakage, and cGAS–STING-driven CD8 T-cell senescence — mechanistically fuels tissue damage and correlates with human disease severity and treatment non-response. It extends the mtDNA–cGAS–STING senescence pattern already documented in macrophages, astrocytes, RPE, and hepatic immune cells into an adaptive-immune (CD8 T cell) compartment, and adds a chronic inflammatory bowel disease to the list of indications where senolytic clearance is proposed as a mechanism-directed lever. The gap remains standard for this axis: mouse causal chain plus human correlational signal, no interventional readout in patients.

Source

Link

Briefing card

NADMetabolic Reprogramming Drives CD8T Cells Senescence and Exacerbates Ulcerative Colitis.
Stage: preclinical · pubmed · 01-sep-2026

If you follow NAD precursors or senolytics for aging, this preclinical work extends their rationale to ulcerative colitis via senescent CD8 T cells, but does not show that either intervention treats IBD in humans.

NAD metabolic dysregulation drives mitochondrial dysfunction and mtDNA–cGAS–STING–dependent CD8 T-cell senescence that exacerbates ulcerative colitis, and clearing these senescent cells with senolytics attenuates disease.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1111/acel.70706

build build 880 · 2bcef25 · 2026-11-18